Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis
Sign Up to like & getrecommendations! Published in 2020 at "Gut and Liver"
DOI: 10.5009/gnl20074
Abstract: Background/Aims The clinical significance of partial virological response (PVR) in patients undergoing antiviral therapy is not well known. This study investigated whether PVR after 2 years of entecavir (ETV) therapy is associated with hepatocellular carcinoma… read more here.
Keywords: therapy; partial virological; virological response; fib index ... See more keywords